Skip to main content

Drugs: Northern Ireland

Question for Department of Health and Social Care

UIN HL15141, tabled on 21 April 2021

To ask Her Majesty's Government what discussions they have held with drug and medicine manufacturers in relation to the withdrawal of medicines from sale in the Northern Ireland market because of the costs resulting from the operation of the Protocol on Ireland/Northern Ireland.

Answered on

29 April 2021

The Department, the Medicines and Healthcare products Regulatory Agency and the Northern Ireland Department of Health are continuing to work closely with industry partners and will continue to do so throughout 2021 to help ensure the continuity of supply of medicines to Northern Ireland. This includes regular and intensive engagement with industry to understand any issues and to support them in their preparations to comply with the Protocol.